An interventional study of Control and Sit-and-stand desk in Sedentary Behavior and Occupational Stress, sponsored by University Hospital, Clermont-Ferrand. Recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-10.
Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Prevention
The purpose of the study is to study changes in sedentary behavior following a behavioral intervention (sit-and-stand desk, and cycloergometer)
Each emergency medical services dispatcher and each firefighter participates in the study for three days. A normal working day from of 12h is compared to: (i) a working day during which the participants have to get up at least 5 min/hour (sit-and-stand desk), (ii) a working day during which they can use a cycloergometer installed under the desk. Conditions will be random using Latin Square design with stratification between sequences cross-over design on occupation (EMD vs. firefighters).
The heart rate variability (measured using Zephyr®), the electrodermal activity (Empatica® E4), the level of physical activity (Actigraph®) as well as the blood sugar (Freestyle®) will be measured continuously during the 12 hours of work and the night after except for Actigraph® and Freestyle® device that will be let one week. Blood and saliva samples will be collected on each working day, at the beginning and end of the day i.e. two measures for blood samples, and every three hours i.e. 5 measures for saliva sampling. Participants will have to complete a detailed questionnaire to identify the particular events (vital emergencies, etc.) that may influence the parameters measured.
Participants will be asked to answer a general questionnaire once at the start of the study that will cover different aspects:
They will then have to answer a short questionnaire at the beginning and at the end of each measurement day. It will cover different aspects:
1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.
This study's planned enrollment of 36 is below the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.
Browse Sedentary Behavior studies →University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 179 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Control · Behavioral: Sit-and-stand desk · Behavioral: Cycloergometer
Behavioral: Control · Behavioral: Sit-and-stand desk · Behavioral: Cycloergometer
A normal working day from of 12h
a working day during which the participants have to get up at least 5 min/hour
a working day during which they can use a cycloergometer installed under the desk
Sedentary behavior
Sedentary behavior measured by actimetry using Actigraph® in number of minutes per day standing/active.
Time frame: 12 hours of work corresponding to the control condition
Sedentary behavior
Sedentary behavior measured by actimetry using Actigraph® in number of minutes per day standing/active.
Time frame: 12 hours of work corresponding to the sit-and-stand desk condition
Sedentary behavior
Sedentary behavior measured by actimetry using Actigraph® in number of minutes per day standing/active.
Time frame: 12 hours of work corresponding to the cycloergometer condition
Sedentary behavior
Sedentary behavior measured by actimetry using Actigraph® in number of minutes standing/active during one week.
Time frame: one-week (168 hours) sit-and-stand desk cycle
Sedentary behavior
Sedentary behavior measured by actimetry using Actigraph® in number of minutes per day standing/active.
Time frame: one-week (168 hours) control cycle
Sedentary behavior
Sedentary behavior measured by actimetry using Actigraph® in number of minutes standing/active during one week.
Time frame: one-week (168 hours) cycloergometer cycle
Heart rate variability
The heart rate variability measured using Zephyr®
Time frame: 24 hours record corresponding to 12 hours of work and the next 12 hours of rest
Electrodermal activity
The electrodermal activity measured using Empatica E4
Time frame: 24 hours record corresponding to 12 hours of work and the next 12 hours of rest
Stress at home
Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the control day
Stress at home
Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the sit-and-stand desk day
Stress at home
Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the cycloergometer day
Stress at home
Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the control day
Stress at home
Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the sit-and-stand desk day
Stress at home
Stress at home measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the cycloergometer day
Fatigue
Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the control day
Fatigue
Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the sit-and-stand desk day
Fatigue
Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the cycloergometer day
Fatigue
Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the control day
Fatigue
Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the sit-and-stand desk day
Fatigue
Fatigue measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the cycloergometer day
Anxiety
Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the control day
Anxiety
Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the sit-and-stand desk day
Anxiety
Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the cycloergometer day
Anxiety
Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the control day
Anxiety
Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the sit-and-stand desk day
Anxiety
Anxiety measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: 6 pm, end of the cycloergometer day
Mood
Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent). Higher scores mean a better outcome.
Time frame: 6 pm, beginning of the control day
Mood
Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome.
Time frame: 6 am, beginning of the sit-and-stand desk day
Mood
Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome.
Time frame: 6 am, beginning of the cycloergometer day
Mood
Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome.
Time frame: 6 pm, end of the control day
Mood
Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome.
Time frame: 6 pm, end of the sit-and-stand desk day
Mood
Mood measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent).Higher scores mean a better outcome.
Time frame: 6 pm, end of the cycloergometer day
Stress at work
Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the control day
Stress at work
Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the sit-and-stand desk day
Stress at work
Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome.
Time frame: 6 am, beginning of the cycloergometer desk day
Stress at work
Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome.
Time frame: 6 pm, end of the control day
Stress at work
Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome.
Time frame: 6 pm, end of the sit-and-stand desk day
Stress at work
Stress at work measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum).Higher scores mean a worse outcome.
Time frame: 6 pm, end of the cycloergometer day
Amount of physical activity
Number of hours of physical activity during the last 24 hours
Time frame: 6 am, beginning of the control day
Intensity of physical activity
Physical activity intensity during the last 24 hours measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity.
Time frame: 6 am, beginning of the control day
Amount of physical activity
Number of hours of physical activity during the last 24 hours
Time frame: 6 am, beginning of the sit-and-stand desk day
Intensity of physical activity
Physical activity intensity during the last 24 hours measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity.
Time frame: 6 am, beginning of the sit-and-stand desk day
Amount of physical activity
Number of hours of physical activity during the last 24 hours
Time frame: 6 am, beginning of the cycloergometer day
Intensity of physical activity
Physical activity intensity during the last 24 hours measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity.
Time frame: 6 am, beginning of the cycloergometer day
Amount of physical activity
Number of hours of physical activity during the working day
Time frame: 6 pm, end of the control day
Intensity of physical activity
Physical activity intensity during the working day measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity.
Time frame: 6 pm, end of the control day
Amount of physical activity
Number of hours of physical activity during the working day
Time frame: 6 pm, end of the sit-and-stand desk day
Intensity of physical activity
Physical activity intensity during the working day measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity.
Time frame: 6 pm, end of the sit-and-stand desk day
Amount of physical activity
Number of hours of physical activity during the working day
Time frame: 6 pm, end of the cycloergometer day
Intensity of physical activity
Physical activity intensity during the working day measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a higher intensity.
Time frame: 6 pm, end of the cycloergometer day
Sitting time
Number of hours sit during the last 24 hours
Time frame: 6 am, beginning of the control day
Sitting time
Number of hours sit during the last 24 hours
Time frame: 6 am, beginning of the sit-and-stand desk day
Sitting time
Number of hours sit during the last 24 hours
Time frame: 6 am, beginning of the cycloergometer day
Sitting time
Number of hours sit during the working day
Time frame: 6 pm, end of the control day
Sitting time
Number of hours sit during the working day
Time frame: 6 pm, end of the sit-and-stand desk day
Sitting time
Number of hours sit during the working day
Time frame: 6 pm, end of the cycloergometer day
Tabacco consumption
Number of cigarette during the last 24h
Time frame: 6 am, beginning of the control day
Tabacco consumption
Number of cigarette during the last 24h
Time frame: 6 am, beginning of the sit-and-stand desk day
Tabacco consumption
Number of cigarette during the last 24h
Time frame: 6 am, beginning of the cycloergometer day
Tabacco consumption
Number of cigarette during the working day
Time frame: 6 pm, end of the control day
Tabacco consumption
Number of cigarette during the working day
Time frame: 6 pm, end of the sit-and-stand desk day
Tabacco consumption
Number of cigarette during the working day
Time frame: 6 pm, end of the cycloergometer day
Tea consumption
Number of cups of tea during the last 24h
Time frame: 6 am, beginning of the control day
Tea consumption
Number of cups of tea during the last 24h
Time frame: 6 am, beginning of the sit-and-stand desk day
Tea consumption
Number of cups of tea during the last 24h
Time frame: 6 am, beginning of the cycloergometer day
Tea consumption
Number of cups of tea during the last 24h
Time frame: 6 pm, end of the control day
Tea consumption
Number of cups of tea during the last 24h
Time frame: 6 pm, end of the sit-and-stand desk day
Tea consumption
Number of cups of tea during the last 24h
Time frame: 6 pm, end of the cycloergometer day
Coffee consumption
Number of cups of coffee during the last 24h
Time frame: 6 am, beginning of the control day
Coffee consumption
Number of cups of coffee during the last 24h
Time frame: 6 am, beginning of the sit-and-stand desk day
Coffee consumption
Number of cups of coffee during the last 24h
Time frame: 6 am, beginning of the cycloergometer day
Coffee consumption
Number of cups of coffee during the working day
Time frame: 6 pm, end of the control day
Coffee consumption
Number of cups of coffee during the working day
Time frame: 6 pm, end of the sit-and-stand desk day
Coffee consumption
Number of cups of coffee during the working day
Time frame: 6 pm, end of the cycloergometer day
Sociodemographic
Sociodemographic will be assessed: gender, age, marital status, children, occupation, and recent stressful event
Time frame: Once at baseline
Sleep quality
Sleep quality measured using visual analogue scale ranging from 0 (Bad) to 100 (Excellent). Higher scores mean a better outcome.
Time frame: Once at baseline
Family support
Family support measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome.
Time frame: Once at baseline
Burnout
Burnout measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: Once at baseline
Job demand
Job demand measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a worse outcome.
Time frame: Once at baseline
Job control
Job control measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome.
Time frame: Once at baseline
Hierarchy support
Hierarchy support measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome.
Time frame: Once at baseline
Colleagues support
Colleagues support measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome.
Time frame: Once at baseline
Effort reward-imbalance
Effort reward-imbalance measured using visual analogue scale ranging from 0 (Minimum) to 100 (Maximum). Higher scores mean a better outcome.
Time frame: Once at baseline
Medical treatment
Medical treatment measured using multi-choice question "do you take long term medication?"
Time frame: Once at baseline
Allergy
Allergy measured using multi-choice question "do you have allergy?"
Time frame: Once at baseline
Average physical activity
Average number of hours of physical activity per week
Time frame: Once at baseline
Average physical activity intensity
Average physical activity intensity per week
Time frame: Once at baseline
Average tabacco consumption
Average number of cigarette per day
Time frame: Once at baseline
Average alcohol consumption
Average number of alcohol glasses per week
Time frame: Once at baseline
Average cannabis consumption
Average number of cannabis joint per week
Time frame: Once at baseline
Average tea consumption
Average number of cup of tea per day
Time frame: Once at baseline
Average coffee consumption
Average number of cup of coffee per day
Time frame: Once at baseline
Average food consumption
Average food consumption of 16 food groups
Time frame: Once at baseline
Diet characterization
"How do you characterize your diet" measured on a visual analogue scale ranging from 0 (Not at all balanced) to 100 (Very balanced)
Time frame: Once at baseline
RPAQ questionnaire
The Recent Physical Activity Questionnaire (RPAQ) assesses the level of physical activity and sedentary lifestyle in adults over the past four weeks. It is divided into three parts: work and study, home and leisure, and finally, stairs and travel. It makes it possible to classify individuals into several categories, one on sedentary lifestyle (low, resistant either 3-7h/day or high or \>7h/day) and one on the level of physical activity (\<8.3 Metabolic equivalent of task(MET).hour/week: inactive or \>8.3 MET.h/wk: active).
Time frame: Once at baseline
MBI questionnaire
The Maslach Burn-out Inventory (MBI) is composed of 22 items designed to assess the three components of the burn-out syndrome: emotional exhaustion (9 items), depersonalization (5 items) and reduced personal accomplishment (8 items). The items are written in the form of statements about personal feelings or attitudes. Items are made of a 7-point scale frequency of feelings, varying from "never" to "every day". The scores for each component of the burn-out syndrome are considered separately. If desired for participant feedback, each score can be coded as low, average, or high.
Time frame: Once at baseline
JDCS questionnaire
The Job Demand-Control-Support (JDCS) questionnaire of Karasek assess job demands, job control and social support through 26 items. The questionnaire measures nine items of job demands, nine items of job control and eight items of social support. Items of JDCS are scored on a four-point Likert-type scale, ranging from 1 = strongly disagree to 4 = strongly agree. Among the 26 items, five negative statements require reverse scoring. From French data, the job strain threshold is set for a demands score higher than 20 and a control score lower than 71; the isostrain threshold is determined from a combining score of job strain and social support lower than 24. We would ask the participants to fulfil the questionnaire from memories that they keep of their work.
Time frame: Once at baseline
ERI questionnaire
The Effort-Reward Imbalance Questionnaire (ERI) is a self-administrated test assessing psychological distress and health problems that may occur when there is an imbalance between the efforts required by the work and the rewards received. We used the 46 items of the French version of the ERI model exploring efforts (six items), over commitment (eleven items), and rewards (seventeen items). Items of ERI were scored on a five-point Likert-type scale, ranging from 1 = disagree to 5 = agree and very disturbed. A ratio extrinsic efforts and rewards can assess the imbalance between these two dimensions. A ratio greater than one defines employees exposed to an imbalance between efforts and rewards.
Time frame: Once at baseline
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 6 am, beginning of the control day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 6 am, beginning of the control day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 6 am, beginning of the control day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 6 am, beginning of the control day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 9 am on the control day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 9 am on the control day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 9 am on the control day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 9 am on the control day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 12 am on the control day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 12 am on the control day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 12 am on the control day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 12 am on the control day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 3 pm on the control day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 3 pm on the control day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 3 pm on the control day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 3 pm on the control day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 6 pm, end of the control day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 6 pm, end of the control day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 6 pm, end of the control day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 6 pm, end of the control day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 6 am, beginning of the sit-and-stand desk day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 6 am, beginning of the sit-and-stand desk day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 6 am, beginning of the sit-and-stand desk day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 6 am, beginning of the sit-and-stand desk day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 9 am on the sit-and-stand desk day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 9 am on the sit-and-stand desk day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 9 am on the sit-and-stand desk day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 9 am on the sit-and-stand desk day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 12 am on the sit-and-stand desk day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 12 am on the sit-and-stand desk day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 12 am on the sit-and-stand desk day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 12 am on the sit-and-stand desk day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 3 pm on the sit-and-stand desk day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 3 pm on the sit-and-stand desk day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 3 pm on the sit-and-stand desk day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 3 pm on the sit-and-stand desk day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 6 pm, end of the sit-and-stand desk day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 6 pm, end of the sit-and-stand desk day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 6 pm, end of the sit-and-stand desk day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 6 pm, end of the sit-and-stand desk day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 6 am, beginning of the cycloergometer day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 6 am, beginning of the cycloergometer day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 6 am, beginning of the cycloergometer day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 6 am, beginning of the cycloergometer day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 9 am on the cycloergometer day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 9 am on the cycloergometer day
Salivary leptin
Salivary leptin measured in ng/dml
Time frame: 9 am on the cycloergometer day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 9 am on the cycloergometer day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 12 am on the cycloergometer day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 12 am on the cycloergometer day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 12 am on the cycloergometer day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 12 am on the cycloergometer day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 3 pm on the cycloergometer day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 3 pm on the cycloergometer day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 3 pm on the cycloergometer day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 3 pm on the cycloergometer day
Salivary cortisol
Salivary cortisol measured in µg/dl
Time frame: 6 pm, end of the cycloergometer day
Salivary DHEAS
Salivary DHEAS measured in pg/ml
Time frame: 6 pm, end of the cycloergometer day
Salivary leptin
Salivary leptin measured in ng/ml
Time frame: 6 pm, end of the cycloergometer day
Salivary ghrelin
Salivary ghrelin measured in ng/ml
Time frame: 6 pm, end of the cycloergometer day
Blood cortisol
Blood cortisol measured in ng/ml or nmol/l
Time frame: 6 am, beginning of the cycloergometer day
Blood cortisol
Blood cortisol measured in ng/ml or nmol/l
Time frame: 6 pm, end of the cycloergometer day
Blood DHEAS
Blood DHEAS measured in µg/ml
Time frame: 6 am, beginning of the cycloergometer day
Blood DHEAS
Blood DHEAS measured in µg/ml
Time frame: 6 pm, end of the cycloergometer day
Blood leptin
Blood leptin measured in ng/ml
Time frame: 6 am, beginning of the cycloergometer day
Blood leptin
Blood leptin measured in ng/ml
Time frame: 6 pm, end of the cycloergometer day
Blood ghrelin
Blood ghrelin measured in pg/ml
Time frame: 6 am, beginning of the cycloergometer day
Blood ghrelin
Blood ghrelin measured in pg/ml
Time frame: 6 pm, end of the cycloergometer day
Blood BDNF
Blood brain-derived neurotrophic factor (BDNF) measured in pg/ml
Time frame: 6 am, beginning of the cycloergometer day
Blood BDNF
Blood brain-derived neurotrophic factor (BDNF) measured in pg/ml
Time frame: 6 pm, end of the cycloergometer day
Blood pro-inflammatory cytokines
Blood pro-inflammatory cytokines measured in pg/ml
Time frame: 6 am, beginning of the cycloergometer day
Blood pro-inflammatory cytokines
Blood pro-inflammatory cytokines measured in pg/ml
Time frame: 6 pm, end of the cycloergometer day
Blood NPY
Blood vascular distribution of neuropeptide Y (NPY) measured in pg/ml
Time frame: 6 am, beginning of the cycloergometer day
Blood NPY
Blood vascular distribution of neuropeptide Y (NPY) measured in pg/ml
Time frame: 6 pm, end of the cycloergometer day
Plan to share: Yes — After contacting the corresponding author and signing a data sharing agreement, investigators will make available the documents and personal data strictly necessary in accordance with laws and regulations (Articles L.1121-3 and R.5121-13 of the Code of Public Health).
Supporting information: Study protocol
Started Mar 2024 (actual). Primary completion is estimated for Mar 2027, 36 months after the start.
Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 36 months is above that.
Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand →